Depletion of GLI3 inhibits castration-resistant PCa formation by disrupting AR/GLI3 crosstalk 45, suggesting that GLI3-specific inhibitors may offer a rational therapeutic strategy for PCa. The gene discussed is AR; the disease is posterior cortical atrophy.